Importantly, the effector and co-stimulatory molecules CD69, CD25, OX40, and 4-1BB that were identified in the scRNAseq analysis also proved to be upregulated at the protein level on GPR56-positive TILs from three different ovarian cancer donors (Figure 3D). Here, TNFRSF4 is linked to ovarian carcinoma.